68Ga-PSMA PET/CT检测前列腺癌PTEN表达缺失的诊断价值:一项初步研究
本研究回顾性纳入75例根治性前列腺切除术前接受多参数MRI和68Ga-PSMA PET/CT的患者,分析103个病灶,其中38个(36.9%)为PTEN缺失。SUVmax与PTEN缺失肿瘤显著相关,患者水平敏感性和特异性分别为0.80和0.77,病灶水平分别为0.83和0.74。SUVmax是PTEN缺失肿瘤的显著预测因子。
要点
- 68Ga-PSMA PET/CT的SUVmax与前列腺癌PTEN缺失显著相关。
- 患者水平SUVmax诊断PTEN缺失的敏感性0.80、特异性0.77。
- 病灶水平SUVmax诊断PTEN缺失的敏感性0.83、特异性0.74。
核心结论
- 68Ga-PSMA PET/CT可有效检测侵袭性PTEN缺失肿瘤。
研究设计与样本
- 回顾性纳入75例根治性前列腺切除术前接受多参数MRI和68Ga-PSMA PET/CT的患者,共分析103个病灶。
主要发现
- 103个病灶中38个(36.9%)显示PTEN缺失状态。
- SUVmax与PTEN缺失肿瘤在患者水平分析(P < 0.01)和病灶水平分析(P < 0.01)中均呈强关联。
- PTEN缺失肿瘤中病理PSMA表达更高。
- 平均表观扩散系数(P > 0.05)和PI-RADS v2评分(P > 0.05)在PTEN缺失与PTEN完整肿瘤间无显著差异。
- SUVmax是PTEN缺失肿瘤的显著预测因子,患者水平OR为7.56(95%CI 2.18-26.24),病灶水平OR为13.66(95%CI 4.32-43.24)。
关键数值与推荐
- 患者水平SUVmax诊断PTEN缺失的敏感性和特异性分别为0.80和0.77。
- 病灶水平SUVmax诊断PTEN缺失的敏感性和特异性分别为0.83和0.74。
临床怎么用
- 可利用68Ga-PSMA PET/CT的SUVmax无创评估前列腺癌PTEN缺失状态,辅助识别侵袭性肿瘤。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Our purpose was to explore the value of 68Ga-prostate-specific membrane antigen (PSMA) PET/CT for detection of phosphatase and tensin homolog (PTEN)-loss prostate cancer. Methods: We retrospectively enrolled 75 patients who underwent multiparametric MRI and 68Ga-PSMA PET/CT before radical prostatectomy. Lesions were outlined on pathologic images, and regions of interest were drawn on matched multiparametric MRI and PET/CT images. Imaging parameters, including average apparent diffusion coefficient and SUVmax, were derived. Immunohistochemical staining was performed to evaluate the PTEN status. The diagnostic performance of imaging parameters was analyzed by receiver-operating-characteristic analysis. Univariate logistic regression analyses were used to evaluate the association between clinical and imaging variables and PTEN status. Results: In total, 103 lesions from 75 patients were analyzed. Of these lesions, 38 of 103 (36.9%) showed PTEN-loss status. Our study showed a strong association between SUVmax and PTEN-loss tumors both in the per-patient analysis (P < 0.01) and in the per-lesion analysis (P < 0.01), yielding sensitivity and specificity of 0.80 and 0.77, respectively, in the per-patient analysis and 0.83 and 0.74, respectively, in the per-lesion analysis. Meanwhile, higher pathologic PSMA expression was found in the PTEN-deficiency tumors. However, there was no significant difference between PTEN-loss tumors and PTEN-intact tumors using parameters such as average apparent diffusion coefficient (P > 0.05) and score on the Prostate Imaging Reporting and Data System, version 2 (P > 0.05). Surprisingly, SUVmax was a significant predictor for detection of PTEN-loss tumors (odds ratio of 7.56 and 95% confidence interval of 2.18-26.24 on per-patient analysis; odds ratio of 13.66 and 95% confidence interval of 4.32-43.24 on per-lesion analysis). Conclusion:68Ga-PSMA PET/CT could effectively detect aggressive PTEN-loss tumors.
引用
- Wang B, Gao J, Zhang Q, et al. Diagnostic Value of 68Ga-PSMA PET/CT for Detection of Phosphatase and Tensin Homolog Expression in Prostate Cancer: A Pilot Study. J Nucl Med. 2019. PMID: 31757845. doi:10.2967/jnumed.119.236059
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。